Navigation Links
STAAR Surgical Announces Fourth Quarter 2012 Results Release Date And Conference Call And Webcast
Date:2/14/2013

MONROVIA, Calif., Feb. 14, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) today announced that it will release its financial results for the fourth quarter ended December 28, 2012 on Wednesday, February 27, 2013 after the market close.  The Company will host a conference call and webcast on Wednesday, February 27, 2013 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss the Company's fourth quarter results and recent corporate developments. The dial-in number for the conference call is 877-941-0844 for domestic participants and 480-629-9692 for international participants.

The Company will also be using slides to illustrate its fourth quarter results and operational progress.  The slides and live webcast of the call can be accessed from the investor relations section of the STAAR website at www.staar.com.A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days.  This replay can be accessed by dialing 800-406-7325 for domestic callers and 303-590-3030 for international callers, both using passcode 4592160#.  An archived webcast will also be available at www.staar.com.

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye.  All of these lenses are foldable, which permits the surgeon to insert them through a small incision.  A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL."  A lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." Over 300,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com.  STAAR has approximately 300 full-time employees and markets lenses in approximately 60 countries.  Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA.  For more information, please visit the Company's website at www.staar.com or call 626-303-7902.

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material.  CONTACT:

Investors

MediaEVC Group

EVC GroupJenifer Kirtland

Amy PhillipsDoug Sherk

724-799-8269415-568-4887
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical Reports Third Quarter 2012 Financial Results
2. STAAR Surgical Appoints Charles Slacik To Its Board Of Directors
3. STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
4. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
5. STAAR Surgical To Present At The 32nd Annual Canaccord Growth Conference
6. STAAR Surgical Reports Second Quarter 2012 Financial Results
7. STAAR Surgical Provides Outlook On Second Quarter 2012 Financial Results
8. STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
9. B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference
10. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
11. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 2017   Dynatronics Corporation (NASDAQ: ... Cynthia L. McHenry (Cyndi) as Vice ... leading Dynatronics manufacturing, distribution, and purchasing operations across ... CEO Kelvyn H. Cullimore, Jr. ... process conducted by the company as it continues ...
(Date:3/29/2017)... NetworkNewsWire Editorial Coverage  ... There are a number of advantages ... economic arguments also favor its legalization. The benefits include increased ... to legalize and regulate marijuana requires an ecosystem of support ... SING Profile ), American Cannabis Company (OTC: AMMJ), Kush Bottles, ...
(Date:3/29/2017)... AVIV, Israel , March 29, 2017 ... agreement in which Exeltis will obtain exclusive marketing rights for Neurim,s ... ... an age-appropriate drug targeted to treat sleep disorders in children with ... be the first sleep medication approved for children. The ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... ... 29, 2017 , ... Altima Technologies, Inc., the maker of ... center assets and audio-video devices has recently updated its Visio Stencils library with ... and download shapes and stencils from http://www.VisioStencils.com. , New devices were ...
(Date:3/29/2017)... Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... of a growing number of cancers and is touted to be the next revolution ... treatment, thus far, has been in the form of immune checkpoint inhibitors such as ...
(Date:3/29/2017)... ... , ... AvePoint , the Microsoft Cloud expert, is pleased to announce ... at the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with a ribbon-cutting ... and Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint employs more ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... first technology to directly address the resolution to globally reduce the harmful use ... patented compound of FDA and TTB approved ingredients that when infused into alcohol, ...
Breaking Medicine News(10 mins):